Data derived from the NCI 60 human cancer cell line database suggests that the status of many components of the CDK1 machinery could potentially play a broad role in sensitivity to chemotherapy that is not only limited to NSCLC cell lines. Here, CDK1 is linked to non-small cell lung carcinoma.